Glavna strana

Stara slovenska vera ozna?ava narodnu religiju i mitologiju Starih Slovena ?iji koreni sežu u III milenijum pre naše ere[1]  i koja je postojala sve do pokrštavanja Slovena u srednjem veku.

Slovensku mitologiju je, na osnovu danas raspoloživih izvora, teško rekonstruisati u celosti[2]. Smatra se da je verovanje u život posle smrti bilo zajedni?ko svim Slovenima.[3] Najzna?ajnija božanstva su Perun, Svetovid, Svarog i Dabog, ali je nemogu?e,sa sigurnoš?u, zaklju?iti ko je bio vrhovni bog slovenskog panteona[4]. Postojanje svetih kipova, odnosno kumira, me?u kojima je najpoznatiji tzv. Zbru?ki stub, je potvr?eno na celokupnom slovenskom prostoru[5][6], ali njihov oblik, izgled i materijal izrade variraju od podneblja do podneblja. Usled razli?itih istorijskih prilika, paganska verovanja Starih Slovena su se zasebno razvijala, zbog ?ega se danas obi?no prikazuju i izu?avaju prema podeli slovenskih naroda na Južne, Isto?ne, Zapadne i danas skoro is?ezle Polabske Slovene (Luži?ki Srbi).

Osnovni izvori za rekonstrukciju verovanja Starih Slovena su, uglavnom prema slovenskom mnogoboštvu negativno nastrojene[2], hriš?anske hronike, zatim narodna verovanja i arheološka gra?a, ali je na osnovu njih nemogu?e utvrditi kako funkcije nekih božanstava, tako i postojanje rodbinskih veza me?u njima[2] ili slovenskog kosmogonijskog mita.

Danas se me?u Slovenima javljaju neopaganske verske organizacije, koje svoja verovanja baziraju na sopstvenim tuma?enjima i dopunama oskudnih izvora o veri Starih Slovena, mahom nau?no sporne[7] Velesove knjige[8]. Iako uglavnom propagiraju povratak prirodi, panslavizam i versku toleranciju, me?u njima ima i onih koji predstavljaju agresivne desni?arske grupe koje zagovaraju nacisti?ku filozofiju krvi i tla

- – -

Patent royalty rates
Patent royalty rates are influenced by the importance of the patent and its value to the products. Some realms of business have conventions regarding royalty rates and other license terms. Royalties are often computed as a percentage of the value of the finished product made by using the patent. To illustrate, the following are prevalent rates within the United States pharmaceutical industry:[9]
a pending patent on a strong business plan, royalties of the order of 1%
issued patent, 1%+ to 2%
the pharmaceutical with pre-clinical testing, 2-3%
with clinical trials, 3-4%
proven drug with US FDA approval, 5-7%
drug with market share, 8-10%
Royalty rates may also be affected by whether a patent is strong (i.e. broadly written, seemingly valid) or weak; whether it is a fundamental patent or merely a slight improvement on a known technology; whether substitute technologies are available or an ability to work around the patent; the extent of the contribution of the patented technology to the value of the final product and whether there are other patents that must also be licensed (in which case there is a practical limit on how much royalty can be paid to license each).
By royalty software – With regards to the actual rates of royalty payments in the industry, the Licensing Economics Review,reported in 2002 that in a review of 458 license agreements, over a 16-year period, it found that an average royalty rate of 7.0%. However, the range extended from zero percent to 50 percent. All of these agreements may not have been at ‘arms length’.
In the Arab countries, it may be found, that a royalty as a percentage of sales may be difficult to transact; a flat fee may be preferred as percentages may be interpreted as ‘profit’.